Jason Aryeh
Director/Board Member presso ORCHESTRA BIOMED HOLDINGS, INC.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Jason M.
Aryeh founded JALAA Equities LP in 1997, where he worked as Managing General Partner and Rio Grande Renewables LLC in 2009, where he worked as Chairman.
Mr. Aryeh also currently works at Ligand Pharmaceuticals, Inc., as Independent Director from 2006, Orchestra BioMed, Inc., as Director from 2018, Cytovia Therapeutics, Inc., as Director from 2021, Anebulo Pharmaceuticals, Inc., as Independent Director from 2021, Orchestra Biomed Holdings, Inc., as Non-Executive Director from 2023, Cytovia Holdings, Inc., as Director, and Omicron Delta Epsilon, as Member.
Mr. Aryeh also formerly worked at Immunomedics, Inc., as Vice Chairman in 2017, Novelion Therapeutics, Inc., as Chairman from 2012 to 2018, QLT, Inc., as Director in 2012, Nabi Biopharmaceuticals, as Independent Director from 2011 to 2012, CorMatrix Cardiovascular, Inc., as Director from 2010 to 2017, Myrexis, Inc., as Independent Director from 2011 to 2013, Cystic Fibrosis Foundation Therapeutics, Inc., as Director from 2011 to 2018, and Old API Wind-down Ltd., as Independent Director from 2016 to 2017.
Mr. Aryeh received his undergraduate degree from Colgate University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 05/03/2024 | 79 447 ( 0.45% ) | 6 M $ | 31/03/2024 | |
| 22/03/2024 | 62 984 ( 0.18% ) | 331 926 $ | 31/03/2024 | |
| 30/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Jason Aryeh
| Società | Posizione | Inizio |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 27/09/2006 |
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 01/03/2021 |
| ORCHESTRA BIOMED HOLDINGS, INC. | Director/Board Member | 26/01/2023 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Director/Board Member | 13/05/2021 |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Director/Board Member | 01/11/2018 |
Omicron Delta Epsilon
 Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Omicron Delta Epsilon operates as an academic honor society. The company was founded in 1963 and is headquartered in Fairhope, AL. | Corporate Officer/Principal | - |
| Cytovia Holdings, Inc. | Director/Board Member | - |
Precedenti posizioni note di Jason Aryeh
| Società | Posizione | Fine |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Chairman | 01/08/2018 |
Cystic Fibrosis Foundation Therapeutics, Inc.
 Cystic Fibrosis Foundation Therapeutics, Inc. BiotechnologyHealth Technology Part of Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc. engages in drug discovery and development. The private company is based in Bethesda, MD. | Director/Board Member | 01/02/2018 |
| ░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Jason Aryeh
| Colgate University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| MYREXIS, INC. | Finance |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| ORCHESTRA BIOMED HOLDINGS, INC. | Health Technology |
| Aziende private | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
CorMatrix Cardiovascular, Inc.
 CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Health Technology |
JALAA Equities LP
 JALAA Equities LP Investment ManagersFinance JALAA Equities LP is an independent hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded by Jason Aryeh in 1997 and manages assets of high net worth clients. | Finance |
Cystic Fibrosis Foundation Therapeutics, Inc.
Cystic Fibrosis Foundation Therapeutics, Inc. BiotechnologyHealth Technology Part of Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc. engages in drug discovery and development. The private company is based in Bethesda, MD. | Health Technology |
Omicron Delta Epsilon
Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Omicron Delta Epsilon operates as an academic honor society. The company was founded in 1963 and is headquartered in Fairhope, AL. | Commercial Services |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
| Rio Grande Renewables LLC | |
| Cytovia Holdings, Inc. |
- Borsa valori
- Insiders
- Jason Aryeh
